Drink HRW is on a mission to revolutionize the supplement industry with a new, science-based approach. In just 4 years of availability, various research teams have published 7 clinical trials and 2 case studies using their products, with an additional 15+ clinical trials and 4 preclinical research programs underway. Further, the Drink HRW technology is the only molecular hydrogen supplement on the market to obtain New Dietary Ingredient status after filing with the U.S. FDA.
COQUITIAM, B.C., Oct. 5, 2021 (SEND2PRESS NEWSWIRE) — Aging is a reality that we all deal with, with age-related diseases creating a massive burden on our healthcare system. Now, Drink HRW reports that a new randomized, placebo controlled clinical trial that followed elderly participants for 6 months, published online October 1st in Experimental Gerontology, explains that high doses of hydrogen water (HRW), delivered via hydrogen tablets, could be an effective strategy at improving multiple age-related measurements and outcomes in an elderly population.
COQUITIAM, B.C., July 21, 2021 (SEND2PRESS NEWSWIRE) — The COVID-19 pandemic is creating unprecedented levels of sleep deprivation, which presents a significant risk to mental and physical health, says Drink HRW. Additionally, “COVID-somnia,” a term coined to describe the rising prevalence of insomnia following COVID-19 infection, has begun to emerge.
COQUITIAM, British Columbia, June 8, 2021 (SEND2PRESS NEWSWIRE) — Drink HRW, the industry leader in effervescent tablets to create hydrogen-rich water on demand, announced that they had signed an exclusive partnership with ViloVit, a Russian company dedicated to bringing leading health products to the Russian market, for distribution of Drink HRW branded products across the Eurasian Economic Union, made up of Russia, Kazakhstan, Belarus, Armenia and Kyrgyzstan.
LOS ANGELES, Calif., March 15, 2021 (SEND2PRESS NEWSWIRE) — Drink HRW, the company that revolutionized the supplement industry with its molecular hydrogen tablets, now releases BOOST and BUILD – Ultimate Pre-Workout Performance Supplements.
COQUITLAM, BC, Canada, Jan. 19, 2021 (SEND2PRESS NEWSWIRE) — Drink HRW is excited to announce that a large, double-blind placebo-controlled trial is set to begin this week in France, initiated by the University of Grenoble-Alpes. At the request of the researchers, Drink HRW is supplying the hydrogen tablets for the study as well as a donation to improve the size and scope of the research. It has no other involvement in the research or the decision to publish results.
